CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioForm Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioForm Medical, Inc.
1875 South Grant Street
Suite 200
Phone: (650) 286-4000p:650 286-4000 San Mateo, CA  94402  United States Ticker: BFRMBFRM

This company was Merged or Acquired on 2/12/2010.
This company ceased filing statements with the SEC on 3/18/2010.
Acquired by Merz Pharma Group (Merz GmbH & Co. KGaA)
This company is no longer actively traded on any major stock exchange.

Business Summary
BioForm Medical, Inc. (BioForm) is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient’s appearance. The Company’s product is RADIESSE, an injectable dermal filler designed to provide aesthetic improvement for patients. RADIESSE provides initial aesthetic correction and approximately 12 months’ duration of aesthetic improvement in many patients. The Company has shipped over 1,000,000 syringes worldwide. It has obtained licenses to or acquired three products: Polidocanol, a sclerotherapy treatment in Europe for varicose veins sold under the trade name Aethoxysklerol; BIOGLUE AESTHETIC medical adhesive, a Class III medical device in clinical testing for tissue fixation in browplasty, or forehead lift, and RELAXED EXPRESSIONS System, a radiofrequency 510(k) medical device cleared by the United States Food and Drug Administration (FDA), for use in creating radiofrequency (RF) heat lesions in nerve tissue.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20096/30/2009YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Steven L.Basta 44 6/1/2007 11/1/2002
President, Chief Business Officer Dennis E.Condon 60 2/16/2010 1/1/2004
Principal Financial Officer, Vice President - Finance, Controller, Assistant Secretary FrederickLwee 28 9/1/2009 5/1/2008
5 additional Officers and Directors records available in full report.

Business Names
Business Name
BFRM
BioForm Medical Europe, B.V.
BioForm Medical UK Ltd.
BioForm Medical, Inc.

General Information
Number of Employees: 310 (As of 6/30/2009)
Outstanding Shares: 47,248,211 (As of 1/31/2010)
Shareholders: 126
Stock Exchange: NASD
Federal Tax Id: 391979642
Fax Number: (650) 286-4090


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023